Concepedia

Jeff Blaney

JB

Statistics

Publications

8

Citations

523

H-Index

8

Active since

2008

Affiliations

Gene Therapy Laboratory(Current)

Jeff Blaney is an author at Gene Therapy Laboratory specializing in medicinal chemistry, drug discovery, and pharmacy.

Publications per year

2008–2017

8

Publications

8

SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity <i>in vivo</i>

Sean G. Buchanan, J. Hendle, Patrick S. Lee et al. · Molecular Cancer Therapeutics · 2009 · 131 citations

, , +15

Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors

Emily J. Hanan, Anne van Abbema, Kathy Barrett et al. · Journal of Medicinal Chemistry · 2012 · 90 citations · Full text

, , +14

Learning Medicinal Chemistry Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) Rules from Cross-Company Matched Molecular Pairs Analysis (MMPA)

Christian Krämer, Attilla Ting, Hao Zheng et al. · Journal of Medicinal Chemistry · 2017 · 84 citations · Full text

, , +13

Outcome of the First wwPDB/CCDC/D3R Ligand Validation Workshop

Paul D. Adams, Kathleen Aertgeerts, Cary B. Bauer et al. · Structure · 2016 · 67 citations · Full text

, , +11

Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors

Stephen Antonysamy, Brandon E. Aubol, Jeff Blaney et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 61 citations

, , +12

1–5 of 8